DEA’s final rescheduling brief argues marijuana can no longer remain in Schedule I. What could Schedule III mean for cannabis M&A, valuations, cash flow, distressed assets and strategic buyers?

Federal cannabis reform is moving through both administrative and legislative channels. Whether marijuana is rescheduled or ultimately legalized, cannabis businesses should understand how these changes could affect valuations, mergers and acquisitions, capital formation, and long-term strategy.

Many cannabis business sales don't fail because of price. They fail because of preparation. Learn the most common reasons transactions fall apart and how owners can improve their chances of a successful closing

Distress doesn't always mean failure. In California's evolving cannabis industry, strategic M&A advisory can help operators preserve value, protect stakeholders, and create new opportunities before it's too late.

Not every cannabis business is worth the same. Learn the seven factors sophisticated buyers evaluate when valuing dispensaries, cultivation facilities, manufacturers, distribution businesses, and cannabis real estate in California.

The federal intoxicating hemp ban gives operators one year before enforcement begins—disrupting state hemp markets, shifting demand, and reshaping the future of THC commerce.

California’s cannabis industry is funding child care, environmental cleanup, and public safety — but at what cost? With excise taxes jumping from 15% to 19%, legal operators are being squeezed out while illicit markets thrive. As the LA Times highlighted, the question is clear: can California sustain vital programs and a legal cannabis market, or are we pushing the industry toward collapse?

A massive ICE raid on California’s largest cannabis farm sparks violence, injuries, and urgent questions about ICE raids, labor, and compliance.